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Abstract 
Introduction: Oxygen consumption during prolonged cycling exercise has been extensively 
studied at different work rates and durations, but with the focus primarily on pulmonary 
oxygen consumption (pVO2). The purpose of this study was to use near-infrared spectroscopy 
(NIRS) to investigate the relationship between pVO2 and local oxygenation responses in six 
active leg muscles during prolonged constant-load cycling at different intensities. Methods: 
26 recreational male cyclists performed a constant-load high-intensity cycling test at 75% 
maximal aerobic power (MAP) for 30 min duration or until exhaustion. Of the 26 subjects, 14 
performed a constant-load low-intensity cycling test for the same duration as well, at 50% of 
the work rate found to elicit blood lactate levels of 4 mmol∙l-1during incremental exercise. 
Pulmonary gas exchange (pVO2, RER, VE), heart rate, and NIRS measurements of the 
muscles vastus lateralis (VL), vastus medialis (VM), biceps femoris (BF), gluteus maximus 
(GMax), gastrocnemius lateralis (GL), and tibialis anterior (TA) were obtained continuously 
through both tests, while blood lactate and RPE was measured at specific time intervals. 
Results: Local oxygenation measurement for all the muscles collectively behaved in a similar 
manner as pVO2 at both intensities with an increase in O2 utilization only found in the initial 
phase, and additionally showed a surprisingly homogenous response. However, differences 
were found between the muscle groups with heterogeneity in regard to the amount of 
desaturation at low- and high-intensity. Discussion: Although the local responses were 
similar to each other and that of pVO2, differences were found between the muscles with 
heterogeneity in regard to the amount of saturation. The distal muscles TA and GL showed 
less difference in saturation between low-intensity and high-intensity than the more proximal 
muscles (VL, VM, BF, and GMax). Also the BF and GMax muscles were found to behave 
different with a lack of TSI steady-state during high-intensity. Conclusion: The use of NIRS 
might provide a noninvasive and direct way of measuring local oxygenation responses in 
muscles and provide an indication of the work contribution of various muscles during cycling 
exercise. Although local oxygenation responses across the muscles were in agreement with 
pVO2, difference in amount of saturation was found between muscle groups in the present 
study. Also peripheral differences were found between the subjects able to complete 30-min 
constant-load high-intensity cycling and those who did not.  
Key words: Near-infrared spectroscopy, NIRS, cycling, constant-load, VO2, local 
oxygenation, tissue saturation, SmO2, muscle, muscle groups. 
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Preface 
The data collection for this master thesis was part of a more comprehensive research project at 
the department of Human Movement Science NTNU, on the ongoing debate concerning 
efficiency of the whole body as opposed to the active skeletal muscle. A group of subjects (n 
= 40) were to be followed through a specific training period of 4 months with pre- and post-
testing of physiological measures both at a whole-body and local scale to investigate the 
possible effect of an assigned training program. Additional physiological and performance 
measurements will be included in the main research project, such as cycling efficiency, 
inverse dynamics, cadence, and mVO2. When the data for the present study was collected, 
during the pre-testing period, the cyclists were in off-season with little or none sport specific 
training during the last months. 
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1. Introduction 
Human skeletal muscle is highly dependent upon oxidative metabolism, and the oxygen 
consumption (VO2) may increase up to 50 fold during exercise (Hamaoka et al., 2007). The 
measurement of whole body VO2 by means of measuring pulmonary gas exchange has 
become an established method for studying energy expenditure in the field of both sports 
science and medicine, and has a long history in literature. During constant-load cycling, pVO2 
is repeatedly found to achieve a steady-state condition within the first minutes of exercise, 
where the time to steady-state and rate of increase is dependent on the intensity (Turner et al., 
2006). Although we have required extensive knowledge of pulmonary O2 consumption 
(pVO2) to various activities and intensities, less is known about the oxygen responses on a 
more local level. The known heterogeneity of muscle recruitment during cycling, both in 
terms to various intensities (Bini and Diefenthaeler, 2010, Ericson, 1988)  as well as with 
duration of constant-load cycling (Dorel et al., 2009, Sanderson and Black, 2003), coupled 
with the frequently reported pVO2 steady-state at sub-maximal intensities is an interesting 
topic. 
 The manner of how pVO2 develops during the early transition phase of constant-load 
cycling, and whether it reaches steady-state or not, is highly dependent on exercise intensity 
(Turner et al., 2006). Following the onset of exercise, or a work rate (WR) increment, pVO2 
cannot increase immediately to the steady-state value. Consequently, the active muscles are 
forced to work with oxygen deficit during this transition period, and the energy demand has to 
be met partially from other sources (e.g. O2 stores in the body, stores of muscle 
phosphocreatine (PCr), and minor amounts converted from lactate production) (Xu and 
Rhodes, 1999). When the oxygen supply is insufficient, the generation of ATP has to rely on 
anaerobic glycolysis. This results in the formation of lactate, which seems to play a central 
role in the pVO2 response. At higher power outputs, typically above lactate threshold, pVO2 
either reaches a delayed steady-state above that predicted from lower power outputs, or 
continues to increase until the end of exercise (Xu and Rhodes, 1999). This latter effect has 
been called the slow component of VO2 kinetics by Whipp and Wasserman (1972), and 
numerous studies have demonstrated it to be closely linked with blood lactate ([La
-
]) levels 
(Hagberg et al., 1978, Turner et al., 2006, Whipp and Wasserman, 1972, Xu and Rhodes, 
1999). 
When exercise is performed at work rates below the lactate threshold (LT) (i.e. onset 
of increased anaerobic glycolysis (Beaver et al., 1985), and thus a measurable increase of 
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blood lactate levels), steady-state pVO2 levels are reached within 3 minutes (Pringle et al., 
2003, Stringer et al., 1994, Turner et al., 2006). During heavier exercise, with WR above LT, 
the rate of lactate production initially exceeds the rate of clearance. However, as long as the 
WR is below the maximal lactate steady-state (MLSS) (i.e. the highest work rate that can be 
maintained over time without a continual accumulation of blood lactate (Billat et al., 2003)), 
the lactate level can once again be stabilized at a new but elevated level. This enables a 
steady-state pVO2 during heavy exercise as well, but at a greater pVO2 level than that 
predicated from the relationship between WR and pVO2 during moderate exercise (Pringle et 
al., 2003, Turner et al., 2006, Xu and Rhodes, 1999). When WR is above MLSS, pVO2 can no 
longer be stabilized, and continues to increase until the point of fatigue (Pringle et al., 2003, 
Turner et al., 2006, Xu and Rhodes, 1999). The pVO2 responses to exercise intensity can then 
roughly be divided into three domains, which all can be related to the LT; (1) moderate 
exercise where WR < LT, (2) heavy exercise, i.e. LT < WR < MLSS, and (3) severe exercise 
(i.e. MLSS < WR) (Xu and Rhodes, 1999). 
Although numerous studies have demonstrated a high correlation between the 
magnitude of the pVO2 slow component and blood lactate levels (Stringer et al., 1994, Turner 
et al., 2006), there is, however, no proof to indicate the cause and effect relationship between 
the two variables. Despite that VO2 kinetics have been extensively studied since the first 
report of the exponential nature of gas exchange responses during constant-load exercise 
almost a century ago, the question regarding the mechanism(s) controlling the rate of the 
pVO2 responses remains unanswered (Xu and Rhodes, 1999, Zoladz and Korzeniewski, 
2001). A number of possible factors have been proposed to play a role, such as increased 
muscle temperature (MacDougall et al., 1974, Koga et al., 1997), lactate and H
+
 accumulation 
(Stringer et al., 1994), and activation of additional muscle groups and recruitment of less 
efficient type II fibres (Krustrup et al., 2004, Pringle et al., 2003). In addition, it has been 
suggested that the increase in pulmonary oxygen uptake could simply reflect an increase in 
the cost of ventilation, cardiac output and posture relative to the external power delivered. 
However, Poole et al. (1991) demonstrated that 86% of the additional increase in pVO2 of the 
slow component, seen between 3 and 21 minutes of constant-load high-intensity exercise, was 
attributable to the exercising legs. Hence, a lot of information that could help explain this 
phenomenon is likely located locally within the active muscles. 
The response of pVO2 during incremental exercise is believed to have a linear 
relationship with work rate up to near maximal aerobic power production (MAP) (Ettema et 
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al., 2009, Ettema and Lorås, 2009, Zoladz and Korzeniewski, 2001).  Unpublished data from a 
recent study at the department of Human Movement Science NTNU found during an 
incremental cycling protocol that while pVO2 showed a linear relationship with WR, as 
expected, muscle oxygen consumption (mVO2) of the vastus lateralis and vastus medialis 
muscles did not. Both muscles showed an exponential rise of mVO2 as a function of WR with 
a fast initial increase at lower intensities followed by a plateau at the higher intensities. A 
nonlinear increase in mVO2 of the main muscles involved in cycling suggests increased 
involvement of additional muscles during higher intensity. This is supported by findings of 
other studies using MRI (Reid et al., 2001, Endo et al., 2004), EMG (Dorel et al., 2009, 
Ericson, 1988), PET (Bojsen-Moller et al., 2010), and joint moments (Bini and Diefenthaeler, 
2010) as well. Similar findings have also been reported during prolonged cycling as part of 
the fatiguing progress (Dorel et al., 2009, Sanderson and Black, 2003), suggesting that the 
same coping strategy exists during constant-load cycling. If the recruitment of additional 
muscle groups is, at least, partly responsible for the linear relationship during incremental 
exercise between pVO2 and WR at higher intensities, this could also be a major contributing 
factor to the pVO2 slow component at higher constant-load intensities in representing a coping 
strategy as fatigue occurs, to prevent fatigue from occurring in the main power producer 
muscles, or simply to add to the power production already delivered. 
Even though local measurements related to local muscle activity (e.g. MRI, EMG, 
PET, and joint moments) have been available and applied in several studies, direct 
measurement of muscle oxygen consumption is complicated. Regional measurements of 
oxygen consumption is possible based on the Fick equation (i.e. VO2 = blood flow ∙ (a-
vO2diff). However, this method has been used less frequently due to its invasive nature (blood 
samples), and the fact that application during exercise is cumbersome. Near-infrared 
spectroscopy (NIRS) is a measuring method that allows us a non-invasive, continuous, and 
direct measurement of local oxygenation changes, and with the use of an arterial occlusion 
also can provide us with a quantitative value for local mVO2. Specifically, in the field of 
sports science the advantage of providing a more local measurement together with the easy 
application of the method during exercise can be a major advantage to study muscular 
response to different activities and physiological stress. 
Near-infrared spectroscopy (NIRS) is a non-invasive optical method that utilizes the 
capability of light in the near-infrared (NIR) region to penetrate skin and reach deeper 
structure such as muscle tissue. The NIR light, in the region of 650-to 950-nm (depending on 
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the equipment used) wavelength, is absorbed by chromophores such as hemoglobin, water, 
and lipids (Wolf et al., 2007). As the absorption of hemoglobin (Hb) differs between 
oxyhemoglobin (O2Hb) and deoxyhemoglobin (HHb), the use of two different but specifically 
chosen wavelengths enables us to differentiate between changes in optical density of O2Hb 
and HHb. With the application of a modified Lambert-Beer law, it is then possible to calculate 
the concentration changes in O2Hb, HHb, and total hemoglobin (tHb) (i.e. the sum of O2Hb 
and HHb) (Ferrari et al., 1997). By using two or three additional channels at small measuring 
distance from each other, it is also possible to get a continuous and quantitative measure of 
tissue saturation (Gerovasili et al., 2010). The use of a simple maneuver, arterial occlusion 
(AO), also enables the calculation of a quantitative value for mVO2 (Boushel et al., 2001, 
Gerovasili et al., 2010). Inflating a pneumatic cuff around a limb above systolic pressure is 
thought to achieve a temporary blockade of blood flow (inflow and outflow) within the limb. 
With no blood flow, the linear decrease in O2Hb or Hbdiff (i.e. the difference between O2Hb 
and HHb) can be used to calculate a quantitative measure of mVO2 (in µM/min). This 
technique has been evaluated in vivo with good reproducibility (van Beekvelt et al., 2001b). 
Although NIRS is not yet widely used in exercise physiology studies, the 
measurement method has been used to study the relationship between local oxygenation and 
the slow component of pVO2. Belardinelli et al. (1995b) found a high correlation between the 
magnitude of the slow component of pVO2 and the amount of decrease in O2Hb saturation in 
the vastus lateralis muscle during several constant-load work rates. In addition, Grassi et al. 
(1999) found a significant correlation between the onset of lactate accumulation and onset of 
muscle deoxygenation in the vastus lateralis muscle during incremental cycling. To our 
knowledge, local oxygenation responses have yet to be investigated for several muscles 
simultaneously during prolonged constant-load cycling. While only one study has applied 
NIRS in investigating multiple muscles and muscle groups during incremental cycling 
(Takagi et al., 2013), studies applying NIRS during constant-load cycling (Grassi et al., 1999, 
Belardinelli et al., 1995b) have only investigated parts of the quadriceps muscle. In addition, 
the mentioned studies have merely presented saturation measurements without the raw 
signals, which may exclude valuable information about e.g. blood volume changes. 
The purpose of this study was, therefore, to investigate the relationship between whole 
body pulmonary O2 consumption and muscle oxygenation during prolonged constant-load 
cycling at low intensity (below LT) and at high intensity (well above LT). In addition, to 
study the possible effects of altered muscle recruitment during prolonged cycling exercise, 
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NIRS was used to simultaneously measure local oxygenation responses in six active leg 
muscles. 
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2. Methods 
2.1 Subjects 
26 male recreational cyclists participated in the study. All subjects were recruited through 
several cycling clubs in Norway, and had both cycling experience and competing in various 
recreational races as goal for the next bicycle season. The mean age (SD, range) was 38.6 
years (± 7.0, 23 – 48), height 182.5 cm (± 5.6, 173.2 – 195.1), and weight at onset of the first 
day of testing 83.1 kg (± 6.0, 73.7 – 103.2). We were given permission to conduct the study 
by the local ethics committee and all subjects signed an informed written consent before 
participating in the study. 
2.2 Study Design 
All subjects performed two incremental tests and a constant-load cycling test at high-intensity. 
Of the 26 subjects, 14 did a second constant-load cycling test at low-intensity as well. Testing 
occurred on 2 or 3 separate days in an air-conditioned lab with room temperature of 20-22
O
C, 
with no more than seven days between the first and last day of testing. Information about 
height and age were measured on the first day of testing, while weight was measured at each 
testing day. All subjects were told to avoid hard (> 87% maximum HR) and long exercise 
(>2h) the last day before testing. 
Day 1 consisted of two ramp protocols (Fig. 1) to determine the lactate threshold (LT) 
and maximal aerobic power (MAP), which was used to calculate the intensities for day 2 and 
3. Blood lactate measurements ([La
-
]) were used to determine the LT during the first 
incremental test. Since our CL-LI test was to be of a WR well below LT, the individual’s true 
LT was of less interest, and a WR eliciting a blood lactate level of 4 mmol∙l-1 (OBLA) was 
taken as WROBLA and used in the intensity calculation. Day 2 consisted of 30 min constant-
load low-intensity cycling (CL-LI) at 50% WROBLA, while day 3 consisted of 30 min 
constant-load high-intensity cycling (CL-HI) at 75% MAP. 
2.3 Experimental Protocol 
A schematic representation of the protocols for the tests on day 1 and 2/3, including the 
various methods and the specific time points, is shown in respectively Fig. 1 and 2. 
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2.3.1 Incremental Cycling Tests (Day 1) 
Day 1 consisted of two incremental tests with intermittent measurements of [La
-
] and rating of 
perceived exertion (RPE), and continuous measurement of pulmonary oxygen uptake (pVO2) 
and heart rate (HR). 
 The first test started with a lactate measurement at rest, followed by 4 min unloaded 
cycling. After which, the WR was set at 100 W and increased by 25 W/4min until a lactate 
value above OBLA (4 mmol∙l-1) was reached. [La-] and RPE measurements were collected 
immediately after each increment. In between the tests, the subjects were allowed a maximum 
of 5 min cycling at freely chosen WR and a drink of water. The 2
nd
 incremental test started at 
a WR 50 W lower than WROBLA, and increments of 25 W/min was given until the subject 
reached voluntarily exhaustion. MAP was taken as the highest work rate sustained for a full 
minute. If the subject sustained an additional work rate for 30 seconds, half the increment (i.e. 
12.5 W) was added to the MAP. 
 RPE was collected together with a [La
-
] measurement at the end of exercise to verify 
that the criteria for achieved maximum pVO2 (pVO2max) had been met. Both tests were 
performed at freely chosen cadence (FCC). 
Figure 1: Schematic representation of both incremental tests. FC = freely chosen, RPE = rating of perceived 
exertion, WR = work rate, WROBLA = work rate that elicited blood lactate level of 4 mmol∙l
-1
, pVO2 = pulmonary 
oxygen uptake. Heart rate and pVO2 were measured continuously throughout the test. The test started with a 
lactate measurement, followed by 4 min unloaded pedaling. Next work rate (WR) was set at 100 W, and followed 
by 25 W/4min increments until a blood lactate level of >4 mmol∙l-1 (OBLA) was reached. Lactate measurements 
were taken immediately after each increment. After <5min active rest, the WR was set at WROBLA – 50 W, and 
increased by 25 W/min until voluntarily exhaustion. 
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2.3.2 Constant-Load Low-Intensity Cycling Test (Day 2) 
Day 2 consisted of a 30-min constant-load cycling test at a WR of 50% WROBLA at FCC (Fig. 
2). Because of the low intensity of the test itself, no warm-up was considered necessary. 
 Concentration changes of muscle oxygenation were collected continuously with the 
NIRS apparatus. In order to calculate quantitative measurements of mVO2 (in all the muscles 
except GMax) in analysis, the subjects were exposed to 10 arterial occlusions (AO) during 
exercise. The AOs were applied for 20 sec periods, at the end of every 1 min during the first 5 
min, followed by every 5 min until the end of the test. Coupled with these occlusions, a blood 
sample was collected immediately after each AO, in addition to a baseline measurement prior 
to the test, and analyzed for [La
-
] levels. Also, RPE was collected every 5 min throughout. 
 Gas exchange and HR measurements were measured continuously throughout the test, 
except from 1 min breaks every 5 min from the 6
th
 minute where the subjects were allowed a 
drink of water. 
Figure 2: Schematic representation of the constant-load low-intensity (CL-LI) test. AO = arterial occlusion, 
RPE = ratings of perceived exertion, pVO2 = pulmonary oxygen uptake, NIRS =near-infrared spectroscopy, 
CAD = cadence, WROBLA = work rate eliciting blood lactate levels of 4 mmol∙l
-1
. NIRS, HR, pVO2, and CAD 
were measured continuously throughout the test. The test started with a lactate measurement at rest, and WR 
was then set at 50% WROBLA and remained constant through the entire test. An AO was applied every min during 
the first 5 min, with AO1 40 sec after start of test. Further 5 AOs was applied every 5 minutes thereafter, each 
AO lasting 20 sec. A lactate measurement was coupled with each AO, and taken immediately after deflation of 
the cuff. RPE was taken every 5 min throughout the test. 
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2.3.3 Constant-Load High-Intensity Cycling Test (Day 3) 
Day 3 consisted of a 30-min constant-load cycling test at a WR of 75% MAP at FCC with 
identical protocol as Day 2 (Fig. 2) apart from the work rate and a 5-min warm-up period. The 
subjects performed 5-min warm-up cycling at 50% WROBLA (intensity from Day 2) where the 
WR was gradually increased during the last 20 seconds to enable a correct WR at the start of 
the high-intensity test. A lactate measurement was taken at the end of warm-up in addition to 
the measurements at baseline and during the test. 
 If the subjects were not able to complete a full 30-min cycling at 75% MAP before 
voluntarily exhaustion, the time-to-task-failure (TTF) was registered. 
2.4 Measurements 
All participants cycled on a cycle ergometer with a computer-controlled electro-magnetic 
brake mechanism (Velotron, Racermate inc, Washington, USA), which generates a constant 
power condition, independent of cadence. The seat and handlebar position were adjusted 
according to the subject’s individual preference at the onset of each testing day. All subjects 
wore their own cycling shoes, and had to remain seated during cycling. All tests were done at 
FCC, with pedal rate measured continuously by the ergometer’s recording system (sampling 
frequency of 33.3 Hz). 
Gas exchange values were measured continuously by open-circuit indirect calorimetry 
using an Oxycon Pro apparatus (Jaeger GmbH, Hoechberg, Germany), with a sampling 
frequency of 0.1 Hz. At the beginning of each experiment day, and more often when needed, 
the VO2 and VCO2 gas analyzers were calibrated using high-precision gases (15.00% O2 and 
5.85% CO2, Riessner-Gase GmbH & Co, Liechtenfels, Germany). The flow meter was 
calibrated with a 3 L volume syringe (Hans Rudolph Inc., Kansas City, MO). Heart rate (HR) 
was measured continuously with a sampling rate of 0.2 Hz, using a heart rate monitor (Polar 
RS800, Polar Electro OY, Kempele, Finland). 
Lactate measurements were measured using blood samples taken from the tip of the 
middle and/or ring finger of the left hand at baseline and during exercise. Using 20 µl 
capillaries, blood was collected and analyzed immediately (Biosen Lactate, EKF Industrial 
Electronics, Magdeburd, Germany). The lactate measurement device was calibrated every 60 
min using a 12 mmol∙l-1 standard. 
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The RPE was measured with a revised Borg scale (see appendix I) during cycling 
together with lactate measurements, except during the first 5 minutes of constant-load cycling. 
The subjects were asked to rate their whole body stress during the last WR period on a scale 
from 6 (= resting on a bed) to 20 – “maximal” (Borg, 1982). 
2.4.1 Near-Infrared Spectroscopy (NIRS) 
To measure the local changes in muscle oxygenation and tissue saturation (TSI), continuous 
NIRS measurements were done on the muscles vastus lateralis (VL), vastus medialis (VM), 
gluteus maximus (GMax), gastrocnemius lateralis (GL), tibialis anterior (TA), and biceps 
femoris (BF) of the right leg. The specific muscles were chosen for their known involvement 
in cycling and previous appearances in literature. A continuous-wave near-infrared 
spectrophotometer (Oxymon MKIII, Artinis Medical Systems, the Netherlands) with a 
sampling frequency of 50 Hz, wavelengths of 766 and 856 nanometer, and a source-detector 
distance of 31, 35, and 39 mm was used on BF and VL. In addition, four wireless NIRS 
devices (Portamon, Artinis Medical Systems, the Netherlands) (sampling frequency of 10 Hz, 
wavelengths of 761 and 845 nm, source detector distance 30,35, and 40 mm) were used on the 
remaining muscles. Changes in oxygenation were measured continuously during all tests.  
It is not possible to differentiate between hemoglobin (Hb) and myoglobin (Mb), as 
their absorption spectra overlap (Boushel et al., 2001, Ferrari et al., 2011, Hamaoka et al., 
2007, van Beekvelt et al., 2001a). However, as the focus of this study is on oxygen 
consumption, and not whether it came from Hb or MB, this is less relevant and the sum of the 
two will be presented as Hb in this paper. 
All of the NIRS optodes were positioned on the bulk of the muscle parallel to the 
muscle fibre length, according to the SENIAM guidelines for EMG sensor placement. Some 
exceptions were made for BF and VL. The pneumatic cuff was placed as proximal as possible 
on the right leg, but for some of the shorter subjects the cuff would be placed too far down for 
an ideal placement on BF, and in some cases even VL. In these cases, the optodes were placed 
perpendicular to the muscle length and as close to the bulk as possible. The subjects were 
shaved at the site of optode placements, and the placements were marked with a pen to control 
that the optodes had not moved during the testing, as well as to ensure the same optode 
placement in those subjects who cycled both constant-load tests. 
Skinfold thickness was measured on all the subjects by skinfold caliper measurements 
(Holtain Tanner/Whitehouse skinfold caliper, Holtain Ltd, Crymych, Wales) at the sites of 
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NIRS optode placement, and compared in later analysis. The average of two caliper 
measurements divided by 2 was taken as the adipose tissue thickness thickness (ATT). Thigh 
and calf circumference was also measured at height of the NIRS optodes. 
In order to be able to calculate muscle oxygen consumption (mVO2), arterial 
occlusions were applied at regular time intervals (at minute 1-2-3-4-5-10-15-20-25-30) during 
both constant-load protocols, using a pneumatic cuff that was rapidly inflated/deflated with an 
automatic inflation system (Hokanson E20 Rapid Cuff inflator + Hokanson AG-101 Air 
Source, Marcom Medical ApS, Denmark) set to a pressure of 300 mmHg. The initial goal was 
to include the quantitative measurements of mVO2 as well in this thesis, but due to the limited 
time span, mVO2 will not be presented in this paper, and the focus will rather be on the 
muscle oxygenation. 
2.5 Data Analysis 
Data analysis, filtering, and statistics were carried out in Matlab (7.8.0.347, The MathWorks 
Inc.), Microsoft Excel 2010, and SPSS (20.0, IBM Corp) for Windows. 
2.5.1 Maximum / Peak Values 
Peak heart rate (HRpeak), pVO2max, and MAP were collected from the second incremental test 
on day 1. HRpeak and pVO2max were calculated as the average of the last 30 seconds of the 
MAP test, where pVO2max was reached when 4 out of 5 criteria for pVO2max were met (HRpeak 
> 90%[220 – age (years)], RPE > 18, [La-] > 8 mmol∙l-1, RER > 1.10, plateau in pVO2 (i.e. no 
further increase in pVO2 despite increase in WR)). MAP was calculated as the highest 
completed WR over 60 seconds. If an additional WR was sustained for full 30 seconds, 
  
 
 W 
was added to the MAP value. 
2.5.2 Mean Values 
For analysis purposes, mean values of HR, pulmonary gas exchange, and NIRS cycling were 
calculated from the continuous measurements from the constant-load cycling tests to represent 
specific time points. For the first 5 minutes, averages for pulmonary and HR measurements 
were taken from the last 30 seconds in each minute while NIRS concentration changes were 
taken from the last 10 seconds just prior to each occlusion. For the remainder of the test, 60 
seconds averages were calculated for pulmonary and NIRS from the last minute prior to 
occlusion. HR average was still calculated from 30 second periods, and from one minute 
earlier than pVO2 and NIRS to avoid any effect of the anticipation of an occlusion on the 
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heart rate data (subjects were alerted to the upcoming AO 30-40 seconds prior to the 
inflation). 
 In order to remove the artifacts resulting from the rhythmic contractions and relaxation 
of the muscles during cycling, all NIRS data were filtered using an eighth-order low-pass 
Butterworth filter (10 Hz, zero-lag). To normalize the concentration changes, all baseline 
concentrations measured for 30 seconds prior to the tests were subtracted from all the NIRS 
measurements (except TSI). Hence, baseline was set to zero and the values for the remainder 
of time points during constant-load cycling are relative changes to the baseline concentration. 
2.6 Statistical Analysis 
All statistical analyses were computed using IBM SPSS Statistics 20.0. A one-way ANOVA 
was used to assess possible differences in baseline measurements between the participants 
that completed both CL-LI and CL-HI (group 1) and those who completed only CL-HI (group 
2), as well as between those who completed 30-min CL-HI (G30) and those who did not 
(G<30). The same analysis was used to assess possible differences in ATT between the sites 
of the muscles followed by post-hoc analysis (Dunnett’s T3 for unequal variances) if a 
significant difference was found. When the assumption of normality was violated, the non-
parametric Kruskal-Wallis test was used. To investigate whether the blood lactate level at the 
end of CL-HI was of similar level between G30 and G<30, a one-way ANOVA was also used 
on the ∆[La-] calculated from the end high-intensity lactate value and the maximum achieved 
lactate value from day 1.  
A two-way ANOVA for repeated measures was used for group 1 to examine the 
effects of intensity (CL-LI vs. CL-HI) and time on the various variables pVO2, VE, RER, 
blood lactate, HR, and the concentration changes of O2Hb, HHb, tHb, and TSI for the 6 
investigated muscles. The significance level was set at 0.05, and if the assumption of 
sphericity was violated, significance was adjusted using the Greenhouse-Geisser method. 
When significant differences were found, within-subject contrasts were used to assess 
differences between time points. Due to the fact that not all of the subjects were able to 
sustain more than 15 minutes of the CL-HI test, only the first 15 minutes of the constant-load 
tests were investigated in this analysis to include as many subjects as possible. 
A three-way ANOVA was then carried out in the same way for the same variables to 
test whether the 0 – 15 min response found during CL-LI and CL-HI in group 1 was the same 
between G30 and G<30. When no significant difference between the two groups was found, 
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G30 was used in an additional two-way repeated-measures analysis including time points for 
the 20
th
, 25
th
, and 30
th
 minute. This was done to investigate whether we could find any 
different response between the intensities in the second half of the test (15 – 30 min).  
 A final two-way ANOVA was used to test whether the response during CL-HI 
was similar in group 1 and 2. This way, it would be possible to increase the group size for CL-
HI, and especially for analysis of the second half of the test (15 – 30 min). 
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3. Results 
In total, 26 subjects (n = 26) performed the CL-HI test, of which 14 subjects (n = 14) 
performed CL-LI as well. All participants fulfilled 4 out of 5 criteria set for achieved pVO2max 
during the MAP test on day 1. The subject characteristics are presented in table 1. There was 
no significant difference when comparing the subjects of group 1 and group 2 (tested 
variables: age, weight, height, pVO2max, HRpeak, maximum lactate value, MAP, WROBLA, thigh 
and calf circumference, and skinfold thickness).   
 All subjects in group 1 completed 30-min cycling at low-intensity (n = 14), while only 
a total of 10 (n = 10) from a pool of 26 subjects completed the full 30-min cycling at high-
intensity. The number of subjects in each finishing category as well as the average finishing 
time is presented in table 2. Factors thought to affect endurance performance are presented for 
G30 and G<30 in table 3. No significant difference in the variables pVO2max, maximum 
achieved lactate, MAP, WROBLA, WROBLA in percentage of MAP, ATT, or circumference was 
found when comparing G30 and G<30 (neither for the entire pool of subjects nor for group 1 
and 2 in separated analysis).  
 Significant difference in ATT was found between the muscle sites (p < 0.001), where 
post-hoc analysis revealed the ATT of TA and GMax being significantly lower and higher 
(respectively) than all the remaining muscles (p = 0.000 – 0.001), except from the difference 
between TA and VL (p = 0.065). 
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Table 1: Subject characteristics 
 LI (GR 1) HI (GR 1) HI (GR 2) 
n 14 12 
Age (years) 40.0 (5.7, 32 – 48) 37.1 (8.0, 23 – 47) 
Weight (kg) 82.9 (7.6, 73.7 – 103.2) 83.2 (3.1, 78.1 – 89.2) 
Height (cm) 182.3 (4.6, 173.2 – 189.5) 182.8 (6.5, 174.3 – 195.1) 
pVO2max (ml∙kg
-1∙min-1) 52.6 (6.3, 35.9 – 60.3) 55.6 (4.9, 44.6 – 63.2) 
HRpeak (bpm) 185.1 (10.0, 165 – 203) 184.3 (10.0, 172 – 202) 
Maximum Lactate Value 
(mmol∙l-1) 
12.57 (2.32, 8.1 – 16.8) 12.61 (2.38, 8.7 – 15.8) 
MAP (W) 364.3 (30.9, 300.0 – 412.5) 378.1 (19.2, 337.5 – 412.5) 
WROBLA (W) 230.5 (23.6, 196 – 270) 239.1 (31.8, 176 – 282) 
WR (W) 115.4 (11.9,  
100 – 135) 
273.6 (22.6,  
225 – 310) 
283.3 (13.9, 255 – 310) 
    
ATT (Right VL) (mm) 5.1 (2.3, 3.3 – 11.5) 5.1 (1.6, 2.8 – 8.6) 
ATT (Right VM) (mm) 6.0 (2.0, 3.7 – 9.5) 5.9  (1.5, 3.0 – 8.6) 
ATT (Right BF) (mm) 3.4 (1.1, 2.0 – 6.3) 3.9 (1.7, 1.9 – 8.0) 
ATT (Right GMax) (mm) 9.7 (2.7, 4.8 – 15.3) 10.9 (3.5, 4.9 – 19.5) 
ATT (Right GL) (mm) 5.3 (1.7, 2.9 – 9.6) 6.0 (1.7, 3.9 – 9.0) 
ATT (Right TA) (mm) 3.8 (1.1, 2.3 – 5.5) 3.9 (1.0, 2.5 – 6.5) 
CF (Right thigh) (cm) 57.1 (2.4, 53.5 – 60.3) 57.1 (2.9, 54.0 – 64.0) 
CF (Right calf) (cm) 39.7 (5.3, 33.5 – 57.0) 38.6 (1.3, 35.7 – 41.0) 
 Mean (SD, range) for subject characteristics. pVO2max =maximum whole body oxygen uptake, HR = heart rate, 
MAP = maximal aerobic power, WROBLA = work rate eliciting blood lactate level of >4mmol/l obtained on day 
1, WR=work rate, ATT = adipose tissue thickness, VL = vastus lateralis, VM = vastus medialis, BF = biceps 
femoris, GMax = gluteus maximus, GL = gastrocnemius lateralis, TA = tibialis anterior, CF = circumference 
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Table 2: Finishing time 
 15min 20min 25min 30min TTF (min) 
GR1 LI: n = 14 n = 14 n = 14 n = 14 30.0 (0.0) 
GR1 HI: n = 14 n = 9 n = 6 n = 6 22.9 (6.5) 
GR2 HI: n = 12 n = 10 n = 6 n = 4 24.2 (4.9) 
Total LI: n = 14 n = 14 n = 14 n = 14 30.0 (0.0) 
Total HI: n = 26 n = 19 n = 12 n = 10 23.5 (5.8 
Number of subjects within each finishing group and mean (SD) TTF (=time-to-task-failure) for each subject 
group. GR1 = subjects who performed both low- and high-intensity tests, GR2 = subjects who performed only 
high-intensity test, LI = low intensity, HI = high intensity, TTF = time-to-task-failure. 
 
Table 3: Factors thought to affect performance 
  <30-min 30-min (n = 10) 
  Mean (SD) Min – Max Mean (SD) Min – Max 
pVO2max (ml∙kg
-1∙min-1) 53.4   (6.4) 35.9  – 60.3 55.0   (4.8) 44.9  – 63.2 
Max La (mmol ∙ l-1) 13.03 (2.29) 8.7    – 16.8 11.79 (2.22) 8.1    – 15.8 
MAP (W)  372.9 (24.7) 338   – 413 365.0 (32.7) 300   – 400 
WROBLA (W)  231.4 (25.8) 186   – 277 238.4 (33.3) 176   – 282 
WROBLA (%MAP) 62.1   (5.4) 49.6  – 68.4 65.3   (7.0) 52.2  – 72.8 
∆La (mmol∙l-1) 0.25   (2.15) -4.05 – 3.76 1.41   (2.58) -2.98 – 4.09 
Factors thought to affect performance within the two groups that did and did not complete 30-min of high-
intensity cycling. ∆La = difference in blood lactate level between end MAP and end high-intensitytest. For 
abbreviations, see table 1. 
 
3.1 Whole Body (Systemic) Response 
Individual pVO2 and [La
-
] responses during CL-HI for both group 1 and 2 are presented in 
Fig. 4. After an initial increase in pVO2, no further increase after the 6
th
 minute was seen in 
any of our subjects (n = 26), suggesting that the intensity of 75% MAP was below the MLSS 
threshold. This is, however, in contrast with the increase of blood lactate levels in some of the 
subjects. High levels and continuous increase of [La
-
] were present in several of the subjects 
unable to complete 30-min cycling, with the highest increase of lactate from the 10
th
 minute to 
finish being 4.21 mmol∙l-1. Nevertheless, the ∆[La-] (i.e. ∆[La-] = [La-]end MAP – [La
-
]end CL-HI) 
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was not significant different (p = 0.229) between G30 and G<30, nor was the pVO2 response 
different between the two groups, as can be seen in Fig. 4A. No significant difference was 
found in the response of neither blood lactate (p = 0.454) nor pVO2 (p = 0.226) between 
group 1 and 2. 
 Fig. 5 shows the average responses for the systemic variables (whole body 
measurements) measured in group 1 during both intensities. High-intensity cycling had a 
significant different effect on pVO2 (F (1.80, 19.82) = 29.17, p < 0.001)), HR (F (1.36, 17.61) 
= 33.32), p < 0.001), RER (F (2.24, 24.69) = 44.11, p < 0.001), [La
-
] (F (1.21, 10.87) = 65.28, 
p < 0.001), and RPE (F (2, 26) = 15.85, p < 0.001) compared to low-intensity, with both 
higher overall values and a more pronounced increase during the initial phase of exercise. 
This indicates that the protocol we used produced results in accordance with what can be 
expected of exercise of two substantially different intensities.  
 The difference in effect of the two intensities on pVO2 response is mainly found in the 
first 10 minutes of exercise, where contrasts analysis showed significant differences between 
all time periods (p = 0.000 – 0.014). At both CL-LI and CL-HI, pVO2 shows a steep increase 
from the 1
st
 to 2
nd
 min. However, while pVO2 at CL-LI achieves steady-state already at the 2
nd
 
minute, pVO2 at CL-HI continues to rise with a gentler curve until the 6
th
 minute where 
steady-state is achieved (but not represented in Fig. 5 until the 10
th
 minute). No further 
differences were found between min 10 and min 15. In addition, investigating G30 (n = 6) 
revealed no difference in pVO2 response between the 15
th
 min and the 30
th
 (p = 0.385 – 
0.730), suggesting that the steady-state acquired during the course of the first 15 minutes was 
maintained throughout the last 15 minutes of the test as well. 
 Differences in the responses of RER can also be found in the same initial phase as for 
pVO2, with neither a difference in response between CL-LI and CL-HI from the 10
th
 to 15
th
 
minute (p = 0.378), nor after the 15
th
 minute in the sub analysis of the subjects in G30 (p = 
0.500 – 0.836), when the RER value was at steady-state level. However, while both pVO2 and 
RER reached steady-state at both intensities by the 10
th
 minute, VE, HR, and [La
-
] continued 
to increase at CL-HI also after the 10
th
 minute. 
 HR reaches steady-state early during CL-LI, while it continues to increase during CL-
HI, producing a significant different response from the 1
st
 to 20
th
 minute (p = 0.000 – 0.015), 
and close to significant between the 20
th – 25th min (p = 0.064). The response during CL-HI 
can be divided into two parts; (1) the initial response and (2) post 5 minutes of exercise, with 
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the difference being the steepness of the curve. The second response is most likely related to 
the known effect of prolonged exercise on HR measurements, known as cardiac drift. 
 Sub-analysis for 15 – 30 min was not possible for VE and [La
-
], as the initial response 
(0 – 15 min) was significant different between G30 and G<30. For [La-], this difference 
displayed after the 5
th
 minute, with a much steeper curve between 5 – 10 min and 10 – 15 min 
in the latter group (see Fig. 5D). VE on the other hand, showed a more clearly different curve 
between the two groups, with the 6 subjects in G30 having a more concave curve with a steep 
increase in the first 3 min followed by a more gentle increase, while the response in G<30 was 
more linear during the full 15 min (see Fig. 5E). In other words, ventilation seems to match 
the lactate responses with an inability of reaching a plateau in the <30 min group. 
 
Figure. 4: Group mean (± SD) and individual responses for (A) pulmonary oxygen uptake and (B) blood lactate 
levels for both groups (n = 26) at constant-load high-intensity cycling. Lines represent individual responses 
(grey) and the average of the entire group (black). pVO2 =pulmonary oxygen uptake, La = blood lactate. 
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Figure 5: Mean (± SD) systemic responses for group 1 (i.e. subjects that cycled both low- and high-intensity) at 
low-(open) and high-intensity (filled). (A) pVO2 = pulmonary oxygen uptake, (B) HR  = heart rate, (C) RER  
=respiratory exchange ratio, (D) La  = blood lactate, (E) VE = ventilation, (F)  RPE = rating of perceived 
exertion, CL-LI = constant-load low-intensity, CL-HI = constant-load high-intensity. 14 subjects (n = 14) were 
included to the left of the central vertical black line, while only the 6 subjects who completed 30-min CL-HI are 
represented to the right (n = 6). For La (D), VE (E), and RPE (F) the subjects who completed 30-min CL- HI are 
represented by a separate line (grey, filled) as they showed significant different response during 1 – 15 min than 
those who completed <30min. Asterisks and hash indicate the significant different response between CL-LI and 
CL-HI (* = p < 0.05, ** = p < 0.01, # = p < 0.001). 
3.2 Local Muscle Oxygenation Response 
The unfiltered continuous NIRS signal of VL for one subject during CL-LI and CL-HI is 
presented in Fig. 6. During high-intensity, HHb and O2Hb deviate clearly in the initial phase 
after the warm-up and remains respectively above and below baseline throughout the test. The 
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spikes visible for the HHb/O2Hb signals are a result of the occlusions and can be applied in 
the calculation of mVO2. The mean concentration changes of all the measured muscles for 
group 1 are presented in Fig. 7. No difference in the response between the 8 subjects in G<30 
and those 6 in G30 was found during the first 15 minutes of cycling in VL, VM, GMax, GL, 
and TA. However, a significant difference was found in the response of O2Hb and tHb in BF 
with an earlier and steeper reoxygenation in the latter group. Consequently, the average for 
these signals is separated between the two groups in the figure (Fig. 7). 
 During CL-LI, similar response of O2Hb and tHb can be found in all the muscles; a 
sharp decrease after the onset of exercise, followed by a steady increase throughout the 
exercise. This increase in blood volume (represented by the increase of tHb) to the exercising 
muscles enables muscle oxygenation levels during exercise to reach or exceed the baseline 
levels. Furthermore, the rate of O2Hb increase follows more or less that of tHb in all of the 
muscles, suggesting a steady-state condition in the balance between O2 delivery and O2 
consumption. In other words, the demand is met by the supply.  HHb, on the other hand, show 
some more heterogeneity between the muscles. In the VL, VM, and GL HHb increases after 
onset of exercise, but then decrease and stabilize (but still above baseline level) as tHb 
increases. For the BF, GMax, and TA however, the HHb decreases, and even at later 
stabilized levels remains under baseline level. 
During CL-HI there is a much clearer deviation of HHb and O2Hb during exercise in 
all of the muscles. After the work rate is increased from the warm-up, HHb and O2Hb 
respectively increase and decrease rapidly during the first 2 minutes. By then, tHb is 
increasing in all of the muscles, and eventually leads to tHb concentration above baseline 
level (except from BF). The further initial development of O2Hb in the muscles after the 2
nd
 
minute of exercise differs between the proximal and distal muscles, where TA and GL seemed 
to reach their minimum sooner. However, despite any difference in the initial response, all of 
the muscles show an increase in O2Hb from the 5
th
 – 10th minute as tHb continues to increase, 
followed by a stabilized level from the 10
th
 – 15th minute. The increase in blood volume is, 
however, not enough to enable baseline oxygenation levels during exercise. No significant 
differences was found in the concentration responses during CL-HI between group 1 and 2 (p 
= 0.129 – 0.925) indicating that the described responses for high-intensity were the same for 
26 subjects (n = 26). 
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 Cycling during CL-HI had a significant different effect than CL-LI on the O2Hb, HHb, 
and tHb response in all of the muscles except from O2Hb in TA (p =0.121). Looking at 
within-subject contrasts for VL (the main power producer during cycling), the O2Hb response 
was not significant different between the intensities from baseline to the 1
st
 minute (p = 
0.548), where there were a steep decrease at both intensities, and between the 10
th
 and 15
th
 
minute of exercise (p = 0.291), where stabilized concentration level was achieved at both 
intensities. Otherwise, there were significant differences between all time points (p = 0.000 – 
0.006), where O2Hb started increasing after the 1
st
 minute of CL-LI and continued to decrease 
during CL-HI. The only significant difference for tHb response in VL was between baseline 
and the 1
st
 minute (p < 0.05) and 1
st
 – 2nd minute (p < 0.01), suggesting that an attempt to 
increase blood volume to the exercising muscle was present in similar degree at both 
intensities. However, for those 6 subjects in sub-analysis, tHb response to the intensities was 
significant different in VL from the 15
th
 – 20th minute (p < 0.05) and 20th – 25th min (p < 
0.05), with no further increase of blood volume during CL-HI while it continued to increase 
during CL-LI. As a result of this, significant difference was also found for O2Hb between the 
15
th
 – 20th min (p < 0.01), and the difference between the 25th – 30th min being close to 
significant (p = 0.054). 
 
Figure 6: Unfiltered continuous NIRS signal of vastus lateralis (VL) during 30-min of constant-load low- (A) 
and high-intensity (B) cycling. Lines indicate concentration of O2Hb (red line), HHb (blue), and tHb (green). 
The spikes in the O2Hb and HHb signal is a result of arterial occlusions, which can be used to calculate oxygen 
consumption of the muscle (mVO2). However, mVO2 is not presented in the present study. 
  
26 
 
 
Figure 7: Muscle oxygenation responses in O2Hb (red line), HHb (blue), and tHb (green) for group 1 (i.e. 
subjects that cycled both low- and high-intensity) during low- (left) (CL-LI) and high-intensity (right) (CL-HI) 
constant-load cycling. VL = vastus lateralis, VM = vastus medialis, BF = biceps femoris, GMax = gluteus 
maximus, GL = gastrocnemius lateralis, TA = tibialis anterior. 13 subjects (n = 13) are included to the left of 
the black vertical lines, while only the 6 subjects who completed 30-min high-intensity are represented to the 
right (n = 6). For BF at constant-load high-intensity, O2Hb and tHb of the subjects who completed 30 min are 
represented by separate lines (grey) as they showed significant different response during 1 – 15 min than those 
who completed <30 min. 
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3.3 Tissue Saturation Index (TSI) 
Tissue saturation index (TSI) of all the 6 muscles during CL-LI and CL-HI is presented in 
Fig. 8. The subjects in both G30 and G<30 showed a similar 0 – 15 min TSI response in all 6 
muscles (p = 0.154 – 0.790). Hence, the former group is used for presentation of TSI response 
after the 15
th
 minute.   
 During CL-LI an initial steep desaturation between baseline and 1
st
 minute of exercise 
was present in all of the muscles except the BF and TA, where TSI remained unchanged at 
baseline level throughout the exercise. Also the GMax and GL eventually recovered to 
baseline saturation levels as blood volume increased, and a steady-state was visible at both 
muscles from the 10
th
 minute. The knee extensors VL and VM showed a resaturation as well, 
with a steady-state present from the 10
th
 minute, but none were able to recover baseline values 
(although VM is close with a ∆TSI from baseline to the 30th min of only ~ -3%). VL distinct 
itself further with being the only muscle with an additional desaturation from the 1
st
 – 2nd 
minute. 
 CL-HI had a statistical significant different effect than CL-LI on TSI responses in all 
of the muscles (p = 0.000 – 0.002). In general, none of the muscles are able to recover from 
the initial response during high intensity while all the desaturated muscles showed an increase 
after the initial decrease during CL-LI,. Furthermore, the initial desaturation was also present 
for BF and TA. Although not able to recuperate to baseline levels, most of the muscles still 
acquire a steady-state also at CL-HI within 5 minutes of exercise. The exceptions were BF 
and GMax, where both showed a continuous (but gentle) decrease to the 15
th
 minute. Even 
though VL, VM, GL, and TA all seem to acquire a TSI steady-state, the distal muscles GL 
and TA acquire this earlier (within 2 min) than VL and VM. The TSI response of VL during 
CL-HI is the one that resembles the pVO2 response the most, with an initial steep decrease 
during the first two minutes, followed by a gentler curve until the 5
th
 minute, where steady-
state is achieved. No differences were found in 1 – 15 min TSI response in any of the muscles 
between group 1 and 2 (p = 0.263 – 0.805). 
No difference in 0 – 15 min TSI response was found between G30 and G<30 (p = 
0.263 – 0.805). Within-subject contrasts on the subjects in G30 (n = 6) revealed no significant 
differences in TSI response between low-intensity and high-intensity (p = 0.056 – 0.995) after 
the 15
th
 minute, except from in VM between 25
th
 – 30th min (p < 0.05), suggesting that the 
steady-state acquired in the muscles during the course of the first 15 minutes was maintained 
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throughout the last 15 minutes of the test as well. It may also suggests that the steady-state in 
BF and GMax was most likely eventually acquired in these subjects, but just at a later stage of 
constant-load exercise. 
 
Figure 8: Mean (+/- SD) tissue saturation (TSI) responses for group 1 (i.e. subjects that cycled both low- and 
high-intensity) during low- (open) and high-intensity (filled) constant-load cycling. For abbreviations, see 
previous figure. 13 subjects (n = 13) are included to the left of the central vertical black line, while only the 6 
subjects who completed 30-min high-intensity are represented to the right (n = 6). Asterisks and hash indicate 
the significant different response between constant-load low- and high-intensity (* = p < 0.05, ** = p < 0.01, # 
= p < 0.001). 
3.4 Difference between Finish Groups 
The TSI response of the first 15 min CL-HI between G30 (n = 10) and G<30 (n = 14), 
including subjects from both group 1 and 2 (n = 24), is presented in Fig. 9. Overall, the TSI 
response in all the muscles seems more or less identical, with the only difference being the 
baseline level and amount of desaturation in some of the muscles. This suggests that there 
were no differences in the balance of peripheral O2 delivery and O2 consumption between the 
finishing groups, even though some were unable to complete more than 15 minutes while 
29 
 
others were only halfway through the test. However, an exception can be spotted in GMax, 
where those close to voluntarily exhaustion show a close to significant difference from the 5
th
 
to the 10
th
 minute (p = 0.064) and a significant difference from 10
th
 – 15th min (p <0.001) with 
a decrease in saturation. During the same period, the only difference in any of the other 
muscles can be found in BF from the 10
th
 – 15th minute (p < 0.05). Although the response was 
not found significant different, the amount of desaturation in VL and VM is also less in G<30 
with the same TSI baseline at both groups. 
 
Figure 9: Mean (+/- SD) tissue saturation (TSI) responses during constant-load high-intensity cycling (1 – 
15min) of the subjects who completed 30-min cycling (filled) and those who did not (open). For abbreviations, 
see previous figure. 24 subjects (n = 24) from both group 1 and 2 are included, with a total of 10 (n = 10) 
subjects in the 30-min group. Asterisks and hash indicate the significant different response between the two 
subgroups (* = p < 0.05, # = p < 0.001). 
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4. Discussion 
The main finding of the present study was the similar oxygenation pattern that was found for 
all 6 muscles in response to high-intensity and low-intensity, and achieving a steady-state 
condition during high-intensity within the same time period as pVO2. Although the local 
responses were similar, differences were found between the muscles with heterogeneity in 
regard to the amount of deoxygenation and desaturation. Less difference in saturation was 
found between the intensities in the distal muscles (TA and GL) compared to the more 
proximal muscles (VL, VM, BF, and GMax), as well as a lack of TSI steady-state during 
high-intensity for the BF and GMax muscles. Investigating the TSI response of GMax during 
CL-HI further, we found a significant difference between the subjects in G30 and those in 
G<30. While the group of subjects in G30 maintained the desaturated level achieved by the 5
th
 
minute, G<30 showed a continuous desaturation throughout.   
 To our knowledge, no other studies have investigated multiple muscles during 
constant-load cycling. Takagi et al. (2013) is the only study that has applied NIRS in 
investigating multiple muscles and muscle groups simultaneously during cycling. However, 
they did so during incremental cycling exercise, and not during constant-load cycling. There 
have been other studies that have had more similar protocols to ours, but they have typically 
measured only one or two muscles. In addition, several of the more recent studies applying 
NIRS during cycling exercise have presented only TSI (in many studies referred to as SmO2) 
results and not the raw signal, e.g. the mentioned study of Takagi et al. (2013). TSI is a 
valuable variable to present in an effort to understand human skeletal muscle physiology as it 
reflects the balance between two important mechanisms in the vessels; the oxygen supply and 
oxygen consumption. Furthermore, it provides a more quantified measurement of saturation, 
and thus is easier to interpret and compare across studies. However, when leaving out the raw 
signals one loses important information about e.g. blood volume changes, which can be of 
great assistance in interpreting the TSI results. Also, in our study we found greater between-
subjects variability in TSI than we did for the raw signals. 
 No data is available on the validity of the saturation percent, and how large the 
variability is within a group of subjects. However, a substantial variability is present in both 
Takagi et al. (2013) and our study, illustrating the need for further studies to address this 
issue. One way to possibly decrease this variability in vivo is by normalizing the TSI to each 
individual’s functional 0 – 100% saturation by the use of a cuff ischemia response. This 
involves inflating a pneumatic cuff proximal of the probes to suprasystolic pressure until a 
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plateau in desaturation is reached. A hyperemic response will occur with the deflation of the 
cuff, and the minimum and maximum achieved saturation can be used to establish a quasi-
quantitative scale through the range of 0 – 100% functional saturation. The desaturation 
measured during dynamic exercise can then be calculated to a percent of this 100% 
desaturation. However, the validity of both the measured and normalized TSI scale remains 
uncertain, and the inclusion of raw data is encouraged either way. With concern to the 
comparison of response as a product of time between the intensities, the lack of such a 
normalized scale does not affect the analysis or results of this study. Also, independent of the 
uncertainty of the validity of the quantitative percentage of TSI, all muscles showed lower 
saturation levels during high-intensity than low-intensity as expected in our study. 
 Another possibility to obtain a quantitative value from the NIRS signal is by using an 
arterial occlusion (AO) during (or immediately after) exercise. In the present study, we found 
significant different oxygenation responses between low-intensity and high-intensity exercise, 
but with a remarkable similar response across the muscles both in terms of intensity and 
duration. However, the concentration changes of O2Hb and tHb still only reflects the balance 
between O2 delivery and O2 consumption and not the actual oxygen consumption in the 
muscle (mVO2). In other words, although we find a steady-state condition in oxygenation, it is 
not to say that the mVO2 remains the same throughout the test. In fact, based on previous 
literature on altered muscle coordination during prolonged cycling (Dorel et al., 2009, 
Sanderson and Black, 2003) there is evidence to suggest otherwise. With the application of 
AO during exercise, and thus controlling the blood flow (i.e. no inflow or outflow), the rate of 
deoxygenation may be used to provide us with a more quantitative measurement of mVO2. As 
our initial goal was to also investigate mVO2 during prolonged cycling, the application of AO 
was part of both constant-load protocols, but the results have not yet been analyzed. However, 
we found the occlusion to influence the systemic variables such as pVO2 and HR. Especially 
during the initial phase (5 min) this effect is apparent in our data in a less smooth initial 
increase in pVO2 as to what might be expected based on regression analysis reported in VO2 
kinetics studies. The AO cuts off, in a sense, most of the right leg from the rest of the body. 
With roughly half of the most active muscle mass cut off, and thus a smaller amount of 
muscle mass with the need of oxygen supply, the technique is expected to have some impact 
on the whole-body measurements. We found the HR and pVO2 to decrease respectively 
during and after the AO followed by a compensation period (i.e. increase and overshoot, 
before it again stabilized at pre-AO level). With less muscle mass to supply with oxygen 
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during the AO, a smaller cardiac output is needed, which will lead to a lower pVO2. The 
delayed effect on pVO2 relative to HR may therefore be a systemic delay as cardiac output 
kinetics has been found to be faster than that of pVO2 (Xu and Rhodes, 1999), and/or a delay 
caused by the difference in sampling frequency (0.1 vs. 0.2 Hz). However, as the effect of AO 
was not the primary purpose of this study, we can only conclude that further research is 
needed to make any justified conclusions or interpretations of the effect on pVO2 and HR. 
 The response we saw for pVO2 and HR to the AO has an effect on the analysis, as to 
where one should calculate the averages. For the latter 25 min of the tests, this could easily be 
accounted for by taking the average prior to the occlusion. However, for the first 5 minutes, 
with 20 seconds occlusion every minute, the systemic compensation might have had a greater 
influence on the data as they may either be over- or underestimated.  In the present study, we 
chose to calculate the 30 sec averages for pulmonary and heart rate data from the 10 seconds 
prior to AO plus the 20 seconds of AO, as the greatest effect of the AO was found in the 30 
seconds period after the occlusion. Nevertheless, despite any possible over- or 
underestimation in the initial phase, this effect might not be a problem for our purpose since 
the focus was not so much on the pVO2 kinetics as on the overall difference in response 
between the measured muscles. Moreover, when comparing the same work rate with (0 – 5 
min CL-LI) and without (0 – 5min warm-up phase CL-HI) AO, the average for pVO2 was 
approximately the same for each whole minute. 
4.1 Near-Infrared Spectroscopy (NIRS) 
Because of the relatively small area of NIRS measurement (3 – 4 cm in our study), some 
considerations to regional differences within the single muscle must be made when 
interpreting the results. Both Kennedy et al. (2006) and Kime et al. (2005) have shown such 
differences to exist in the VL muscle at low intensity, but with less/none heterogeneity of 
muscle oxygenation and inter-individual differences during high intensity cycling exercise. 
Regional differences have also been found in blood flow, with a decreased blood flow in the 
distal region compared to the proximal region of the VL muscle (Kime et al., 2005, Mizuno et 
al., 2003). 
Another issue is the possible difference in adipose tissue thickness (ATT) between 
subjects and muscles. In investigating the skeletal muscle, the NIRS light also has to penetrate 
subcutaneous tissue, which may vary considerably between subjects’ ATT. Since the 
measurement debt of NIRS is limited (i.e. approximately half the measurement distance (van 
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Beekvelt et al., 2001a)), a thick skin or fat layer will decrease the amount of light passing 
through the muscle tissue of interest, thereby underestimate the measured muscle oxygenation 
(van Beekvelt et al., 2001a). A method to adjust for differences in ATT has recently been 
proposed by Koga et al. (2011), which may help to provide more comparable data between 
studies and subjects in the future. However, further studies are first needed to standardize this 
method and establish its validity and reliability before it can be widely applied.  
No significant difference in ATT, in any of the muscles, was found when comparing 
the subjects in group 1 and 2. Nor were any difference found between G30 and G<30, thus 
enabling across group comparisons. However, a significant difference was found between the 
muscles, with especially GMax having a higher ATT (Table 1) than the other muscles. As a 
higher ATT underestimate the measured muscle oxygenation, the responses found in our 
study for GMax in comparison with the other muscles may therefore be underestimated as 
well. Also, the ATT average for TA and BF (Table 1) was lower than for the remaining 
muscles. Consequently, the difference found in our study between the TA/BF and the other 
muscles may only be greater. 
4.2 Effect of Intensity 
Systemic and local responses were investigated during two different constant-load intensities 
designed to elicit different systemic responses. In accordance with Xu & Rhodes (1999), we 
hypothesized that CL-LI (WR = 50% WROBLA, i.e. below LT) would provide us with an early 
pVO2 steady-state within 3 minutes of exercise, coupled with no increase in [La
-
] levels. As 
expected, subjects achieved steady-state levels in the systemic variables within few minutes of 
exercise. Furthermore, [La
-
] remained well below LT (Fig. 5D) during the full 30 minutes of 
CL-LI cycling, thus providing evidence that the WR was in fact below the lactate threshold. 
Investigating the local oxygenation responses revealed that an early recovery and surpassing 
of baseline levels was also present in all 6 muscles, with an increase in blood volume enabling 
oxygenation above baseline levels. 
 The initial intention for CL-HI was to select an intensity above each subject’s 
individual MLSS, thought to elicit a pVO2 slow component as well as representing an 
intensity where a possible altered muscle recruitment would surely take place, but still within 
the limit of 30-min tolerance. Ideally, one would then test for the MLSS work rate or the 
critical power (i.e. the highest power one can hold for a theoretically infinite amount of time 
(Miura et al., 2002)) of the subjects by using multiple tests at various work rates. However, as 
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the testing procedure for both variables is greatly time-consuming, it was not feasible for the 
present study. Consequently, the intensity was set to 75% MAP based on evaluation of 
literature with similar protocols and pilot studies in our lab. This relative work rate, without 
consideration for individual lactate thresholds, led to different finishing times ranging 
between 15 and 30 minutes. However, those subjects who completed 30-min rated their 
perceived exhaustion at the end of exercise no lower than those who completed merely 15 
minutes, suggesting an equal level of overall fatigue. 
 Regardless of time-to-task-failure, the high-intensity exercise led to statistical 
significant differences compared to low-intensity in the response of all systemic variables. 
However, no further increase of pVO2 after the 6
th
 minute was present in any of the subjects 
(Fig. 4A), thus suggesting that the WR was collectively in the range of heavy exercise (i.e. LT 
< WR < MLSS) rather than that of severe exercise (i.e. WR > MLSS) (Xu and Rhodes, 1999). 
This is in contrast with the continuous [La
-
] accumulation found in some of the subjects in 
G<30 (Fig. 4B) and the described relationship between these two variables (Jones et al., 2011, 
Xu and Rhodes, 1999). Nevertheless, all systemic variables showed responses in accordance 
with what can be expected of intensities above LT. 
 A clear effect of work intensity was also present in the local oxygenation response, 
where O2Hb and HHb deviated to a greater extent early on during high-intensity in all 6 
muscles (Fig. 7). Blood volume increases during high-intensity both intensities, but while the 
increase during low-intensity was enough to enable recovery of baseline oxygenation levels, 
O2Hb and HHb remained respectively below and above baseline levels during high-intensity 
cycling. However, the oxygenation level stabilized in most of the muscles within 5 minutes, 
where also little or no further increase in tHb was present (except from VM). Depending on 
the different muscle groups, and their involvement in cycling (for a review, see Hug & Dorel 
(2009)), this plateau may suggest one of several things; (1) the work performed by the muscle 
does not demand further deoxygenation, (2) the muscle(s) has reached its minimum 
oxygenation level, or (3) an impaired blood flow hinders the increase of O2Hb delivery. 
Redistribution of blood flow in the legs have been found to occur predominantly during mild 
to moderate exercise (Asanoi et al., 1992), while an increase in blood flow during severe 
exercise is thought to depend on an increase in cardiac output (i.e. heart rate x stroke volume). 
A continuous increase in heart rate is present during high-intensity, but without measurement 
of stroke volume we cannot be sure whether this increase is a result of an effort to increase 
blood flow or to the phenomenon cardiac drift (i.e. an increase in heart rate and a reduction in 
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stroke volume, while cardiac output remains the same), which is repeatedly reported in 
prolonged exercise studies (Cheatham et al., 2000). If an effort to increase blood flow is 
present, the blood flow to some of the working muscles (e.g. VL) may be impaired due to 
intramuscular pressure exceeding perfusion pressure (Sadamoto et al., 1983). That is, the 
requirement of force production during CL-HI exceeds the critical point for further increase in 
blood flow to the muscles. However, as this is out of the scope of this study, further research 
is necessary to provide more founded interpretations. 
4.3 Pulmonary O2 Consumption vs. Muscle Oxygenation 
The main finding of the present study was that local oxygenation measurement for all the 
muscles collectively behaved in a similar manner as pVO2, and additionally showed a 
surprisingly homogenous response. During CL-LI, an intensity that got ratings exclusively 
from the lower end of the Borg scale, the demand for O2 delivery to produce the required 
work aerobically is easily met. The oxygenation level in all the measured muscles decreases 
in the initial phase, most likely because of the mechanical effect of contraction in squeezing 
the blood out of the muscle. However, as heart rate and pVO2 increases, so does tHb, enabling 
oxygenation at or above baseline level in all of the muscles except TA.  
 During CL-HI, it takes longer time to reach pVO2 steady-state, and O2Hb and HHb 
deviate to a larger extent. This deviation in O2Hb and HHb occurs after 5 min warm-up at the 
same intensity as the CL-LI test, thus clearly illustrating a higher need for oxygen in all the 
measured muscles. During this transition period, tHb starts to increase in all of the muscles 
rather rapidly (within approximately 1 – 3 min) after the initial immediate decrease while 
O2Hb levels remain either at the same level or continue to decrease before a resaturation 
period between 5 and 10 min of cycling (except from VL). After 10 min of exercise, there is a 
steady-state present in both local oxygenation and pVO2. The finding of VL not showing any 
resaturation may suggest that the muscle is working at its maximum capacity and has reached 
its plateau in deoxygenation, while an impaired blood flow hinders any possible resaturation. 
 The relatively delayed reoxygenation compared to the early increase in tHb is 
interesting. Chance et al. (1992) studied the resaturation of the quadriceps muscle (RF (i.e. 
rectus femoris), VL, and VM) at rest after several intermittent sub-maximal loads during 
cycling. They found the time of resaturation of hemoglobin in the muscles to be prolonged as 
the intensity increased, and that the blood volume returned to a resting level faster than the 
resaturation of hemoglobin. The authors contributed this finding to a repayment of oxygen 
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deficit at higher work rates. Whether the delayed resaturation relative to the increase in tHb in 
our study is a result of any such repayment in the muscle is not possible to conclude based on 
the available data. However, Chance et al. (1992) investigated resaturation after exercise, and 
their results are thereby in agreement with studies on O2 kinetics on a pulmonary level, where 
any oxygen deficit acquired during the initial phase after onset of exercise is argued to be 
repayed after exercise (Xu and Rhodes, 1999, Whipp and Wasserman, 1972). Consequently, 
there is no evidence to suggest that any such repayment occurs during exercise. Thus the 
delayed resaturation we see during high-intensity may just as well represent a further increase 
in mVO2 enabled by the early increase of tHb. Nonetheless, further research is needed to 
enlighten any possible underlying causes for the delayed reoxygenation during high-intensity 
cycling. 
 The steady-state found in pVO2 and local oxygenation between the 10
th
 and 15
th
 
minute was also found throughout the full 30-minutes for those 6 subjects who completed 30-
minutes at both intensities. This suggests that the O2 steady-state found on a pulmonary level 
at both intensities is also reflected by a steady-state balance between oxygen delivery and 
utilization found on a local level. The adjustments for improving the balance between O2 
delivery and utilization are in other words first and foremost found in the initial phase of 
constant-load exercise. 
4.4 Tissue Saturation Index (TSI) 
Studies that have applied NIRS during dynamic exercise typically report the results in terms 
of oxygenation index (i.e. Hbdiff = ∆[O2Hb – HHb]) or tissue saturation index (TSI), both 
reflecting the balance between oxygen supply and consumption in small vessels in the muscle. 
The measurement of TSI requires multiple measurement distances, but provides a more 
quantified measurement of saturation. Most previous studies have typically investigated parts 
of the quadriceps muscle, while Takagi et al. (2013) is the only study (to our knowledge) to 
investigate several muscle groups simultaneously, but did so during incremental cycling with 
20 W/min increments and not using specifically trained cyclists.  
 From Fig. 8 it is clear that the amount of desaturation and the initial response is 
different between low-intensity and high-intensity in all of the muscles. The VL muscle is 
thought to be the most active leg muscle in cycling and has consequently been used frequently 
in NIRS literature. In our study, the VL is the muscle that resembles pVO2 the most in terms 
of TSI response, with a rapid desaturation during the first two minutes of exercise at both 
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intensities, but followed by a TSI steady-state at low-intensity and a continued gentler 
desaturation at high-intensity. The desaturation during high-intensity continues until the 5
th
 
minute, before a steady-state is present at the 10
th
 minute, also in agreement with pVO2. CL-
LI and CL-HI were found to elicit an average pVO2 steady-state of respectively ~45% and 
~95% of pVO2max. Comparing the ∆TSI from rest to TSI steady-state in VL to similar 
intensity levels in the study of Takagi et al. (2013) (40% and 100% pVO2peak), our results are 
of similar value for CL-LI (3% vs. 4%) but substantially higher for CL-HI (10% vs. 24%). 
This difference could be a result of different training status in the subjects, as Takagi et al. 
(2013) included generally healthy young men that had not participated in any type of 
endurance training program for the last 12 months, while we included specifically recreational 
cyclists that perhaps have the ability to achieve lower saturation level in VL during severe 
exercise. However, the difference could also, at least to some extent, be a consequence of the 
different protocols (i.e. incremental vs. constant-load cycling protocol). 
 Also Grassi et al. (1995) and Belardinelli et al. (1995a) investigated the saturation in 
VL (using Hbdiff) during incremental exercise, and they found the pattern of change in 
saturation to depend on whether the exercise intensity was below or above the subject’s LT. 
This is in accordance with the results of Takagi et al. (2013), where there is a steeper decrease 
in saturation after 60% pVO2peak (an intensity level where one can expect to find the LT in 
normal healthy subjects (Belardinelli et al., 1995a), as well as with the difference found 
between the intensities in our study. Belardinelli et al. (1995a) concluded this finding to be 
owed to the Bohr effect. That is, at low-intensity exercise the O2 supply is sufficient to meet 
the aerobic demand for ATP resynthesis, while at intensities above LT the accumulation of 
muscle lactate ultimately shift the Hb dissociation curve to the right and enables greater O2 
extraction form the capillaries. 
 While a difference between low-intensity and high-intensity was most pronounced in 
VL and the other proximal muscles (BF, VM, and GMax), it was much less in the distal 
muscles (GL and TA). Both GL and TA showed an initial desaturation during high-intensity 
followed by an early stabilized level at similar saturation index as during low-intensity. 
However, while TA showed no initial desaturation during low-intensity, GL had a similar 
initial desaturation at both intensities, but increases gradually to a saturation level equal to that 
of baseline by the 10
th
 min during low-intensity. This is similar to the results of Takagi et al. 
(2013), where the TSI of TA remains unaltered to the WR increments until the intensity 
exceeds 60% pVO2peak, while changes in GL TSI can be seen at all increments. The ∆TSI 
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during CL-LI is also similar to the mentioned study (GL: 0% vs. 1%, TA: -1% vs. 0%), while 
a 4% higher and a 6% lower ∆TSI was found for respectively GL and TA during CL-HI. This 
difference is most likely caused by the better trained cyclists in our study (Chapman et al., 
2008). A possible explanation for the different response and ∆TSI between these two muscles 
may be a result of mono- vs. bi-articular muscles and what is known about these muscles and 
their participation during cycling. While mono-articular muscles are generally believed to 
have the role as power producer muscles (Ryan and Gregor, 1992), and one would expect the 
power production for dorsiflexion to be low at lower intensities such as 50% WROBLA as well 
as at high intensity for experienced cyclists, bi-articular muscles are thought to be primarily 
active in the transfer of energy between joints and in controlling the direction of force 
production on the pedal (van Ingen Schenau et al., 1992). EMG studies on the gastrocnemius 
muscle have shown it to have a constant EMG activity level at lower intensities in the range 
below 70% MAP (Hug et al., 2004, Jorge and Hull, 1986), which is in accordance with the 
similar initial response for the muscle seen in our study between the intensities. The general 
low activity of GL during cycling compared to mono-articular muscles (Hug and Dorel, 
2009), would then suggest that the increase in blood volume following onset of exercise is not 
impaired (i.e. less activation → less force production → less impairment), and thereby enough 
to recover baseline subtraction. 
 In the study of EMG activity level of several main lower limb muscles during 
constant-load exercises at different work rates, Ericson (1988) found increased EMG activity 
level in VL, VM, BF, and GMax (among others) as power output increased from 120 to 240 
W. Furthermore, it was suggested that especially GMax activity is greatly influenced by the 
work rate level with a relative higher activity during high intensity exercise when compared to 
VM. This is in accordance with the results of the present study, where a significant difference 
in saturation response between the intensities is found for the same muscles. This response is 
also most distinctly different in GMax, with a more pronounced effect of intensity in the 
period after the initial start with a recovery of saturation during low-intensity and a further 
decrease during high-intensity despite an increase in tHb. In addition, because of the high 
ATT for the GMax muscle, this difference may be underestimated. Similar response was also 
found for BF during high-intensity. The unaltered saturation response in VL and VM coupled 
with the desaturation present in BF and GMax during high-intensity may suggest an altered 
muscle coordination during exhaustive exercise. There have been found a significant increase 
in the EMG activity level of VL and VM during constant-load exercises to exhaustion at high 
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intensity cycling (Housh et al., 2000, Petrofsky, 1979), suggesting that additional motor units 
of the muscles are recruited to compensate for the decrease in force in the fatigued muscle 
fibers (Dorel et al., 2009). Also the mechanical pattern at the end of prolonged exhaustive 
exercise has been shown to change (Sanderson and Black, 2003), strongly suggesting that the 
muscle coordination is affected by fatigue. Dorel et al. (2009) found in their study of constant-
load exercise an increase in EMG activity level in both GMax (29%) and BF (15%). This 
supports that the desaturation apparent in GMax and BF in the present study during high-
intensity but not low-intensity may reflect a coping strategy to counteract fatigue in VL and 
VM and/or an increase in force production by the knee flexors (Elmer et al., 2011) and hip 
extensors to add to the maximum capacity already delivered by the knee extensors. 
4.5 Finishing Groups 
In the present study, a total of 24 subjects completed CL-HI at 75% MAP, and all subjects 
rated themselves within the same range on the Borg scale, suggesting an equal overall 
perception of fatigue. However, only 10 of the subjects sustained the full 30-min duration that 
was scheduled. When comparing baseline characteristics that were thought to be determining 
factors for performance (WROBLA in absolute (W) and percentage of MAP, VO2max, MAP, and 
max achieved lactate), no statistical significant differences were found between the two 
groups (i.e. G30 and G<30). Nor did we find any difference in the initial response (0 – 15 
min) for pVO2, HR, and RER. The only difference found between the two groups on a whole-
body scale were [La
-
] and VE responses during CL-HI. In G30, the initial fast increase in VE 
flattened more as compared to G<30 where it continued to increase as in Hagberg et al.’s 
study (1978) with normal healthy adults (non-cyclists). In agreement with VE, [La
-
] showed a 
much steeper increase in G<30. A general principle to explain coupling between blood lactate 
and ventilation is pulmonary buffering due to acidification under high intensity through an 
increase in pVCO2, and thus the need for an increase in VE (Perrey et al., 2003). In other 
words, the difference in VE response between the groups may merely be a result of the 
difference found in the accumulation of blood lactate. When comparing the subjects’ end 
results of CL-HI, no significant difference was found in ∆[La-] from the maximum achieved 
lactate during from day 1, nor were there a visible difference in end VE level, thus the 
difference is found in the rate of accumulation and not end values. Our results are thereby in 
agreement with that the exercise intensities associated with the discontinuities in both blood 
lactate accumulation and ventilation are highly related to the exercise intensity that can be 
tolerated during sustained exercise (Billat et al., 2003, Stegmann and Kindermann, 1982). 
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 Well trained cyclists are expected to have high absolute values of VO2max, but they 
separate themselves perhaps first and foremost from the recreational level in the ability to 
work at a higher percentage of their aerobic capacity without high levels of lactate, and 
subsequently early fatigue (Lucia et al., 2001). In this line of thought, it is easy to suggest that 
the subjects in G30 were better trained cyclists who were able to sustain the same level of 
relative intensity (%MAP) for a longer duration, with less accumulation of [La
-
]. If so, this is 
not clear from the difference in WROBLA as percentage of MAP between the two groups, with 
a mean difference of only 3.2% in favor of G30. One possible explanation for this is that 
OBLA is not the same as the individual lactate threshold, and the single reference at a blood 
lactate concentration of 4 mmol∙l-1 may be too simplistic (Beneke et al., 2000, Foxdal et al., 
1996, Billat et al., 2003, van Schuylenbergh et al., 2004). However, a fixed lactate threshold 
of 4 mmol∙l-1 has been found to overestimate the individual threshold in more aerobic trained 
subjects (Billat et al., 2003, Stegmann et al., 1981). Hence, if the subjects in G30 in fact were 
better aerobically trained (i.e. typically better trained cyclists) the mean difference in 
individual lactate threshold may be less. Nonetheless, the blood lactate response of G30 
resembles to a great deal what have been found in highly trained cyclists cycling at critical 
power for a tlim of 30 minutes (Jenkins and Quigley, 1990), thus suggesting that some 
important factor for performance is overlooked in our whole-body measurements. 
 Although no difference in pVO2 response during CL-HI was found between G30 and 
G<30, physical training is known to cause adaptations to not only the cardiopulmonary 
system (typically measured by an increase in pVO2max) but also the peripheral system. This 
has also been supported in NIRS studies, with high correlation between peripheral effects of 
training and cycling performance (Costes et al., 2001, Neary et al., 2002). In investigating TSI 
response during 0 – 15min of CL-HI, we found a significant difference in the response of 
GMax between G30 and G<30. While G30 is able to sustain the desaturated level achieved by 
the 5
th
 minute, G<30 show a continuous desaturation. This is in line with the earlier 
mentioned increased GMax activity found in EMG studies during exhaustive exercise, and 
may further be connected to the lesser amount of desaturation found in VL and VM for G<30. 
While the 30-min group were able to sustain further 15 minutes of exercise, 7 of the 16 
subjects in G<30 had reached voluntarily exhaustion by 15 minutes. This may reflect a need 
for the GMax to contribute relatively more to the force production in the <30 group compared 
to G30. However, as TSI only reflects the balance between local O2 delivery and O2 
consumption, we cannot conclude whether there is an increase in force production and/or 
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muscle activity of GMax. Nevertheless, a significant difference between the two groups that 
may have been a contributing factor to their performance was found on the peripheral level 
using NIRS, and the need for further studies coupling other measurement techniques with 
NIRS (e.g. inverse dynamics, EMG) on several muscles during exhaustive exercise is needed 
to help explain this further. 
  
42 
 
5. Conclusion 
This is the first study to measure local oxygenation responses to constant-load cycling in 
several muscle groups simultaneously. The main finding of the present study was that local 
oxygenation measurement for all the muscles collectively behaved in a similar manner as 
pVO2 at both intensities, and additionally showed a surprisingly homogenous response. 
However, although the local responses were similar, differences were found between the 
muscles with heterogeneity in regard to the amount of desaturation. We found the distal 
muscles TA and GL to show less difference in saturation between the two intensities 
compared to the more proximal muscles (VL, VM, BF, and GMax), as well as a lack of TSI 
steady-state during CL-HI was found for the BF and GMax muscles. These findings are in 
agreement with previous EMG studies that have found GL to show steady activity during low 
intensity cycling (<70% MAP) while the activity of BF and GMax have showed to increase 
with increasing work rate and duration. Another interesting finding was found when 
comparing G30 and G<30. While none of the baseline characteristics were significant 
different between the two groups, and the only significant differences in whole-body 
measurements were found in [La
-
] and VE responses, we found peripheral differences that 
may have contributed to their performance. G30 showed less desaturation in VL and VM as 
well as a significant different response in GMax TSI. While G30 maintained the desaturated 
level in GMax achieved by the 5
th
 minute, G<30 showed a continuous desaturation 
throughout. This may reflect a strategy to add to the maximum capacity already delivered by 
the knee extensors, which then hypothetically may have been less in the latter group. 
Changing the work rate in individual muscles may also be a strategy to counteract early 
fatigue in the first recruited muscles. However, as the measurement of TSI only reflects the 
balance between O2 delivery and O2 consumption, future studies investigating actual muscle 
oxygen consumption coupled with measurements of local work rate through inverse dynamics 
may help us to gain a better understanding of both mVO2 and muscle use during prolonged 
cycling. This study also underlines the need for knowledge of peripheral differences when 
assessing training status in an elsewise homogenous group, as well as illustrating how the use 
of NIRS can provide a new, more direct way to study what is happening in the local muscle 
during exercise. 
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Appendix 
Appendix I. Revised version of the Borg scale for Rating of Perceived Exertion. 
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Appendix II. ANOVA repeated measurement analysis of systemic variables 0-15 min. 
pVO2 (ml/kg/min) 
 
DF1 DF2 F sig. 
Time  2,56 145,04 363,58 0,000 
Intensity 1 11 496,33 0,000 
Time*intensity 1,8 19,82 29,17 0,000 
 
  
  
  
G30 vs. G<30   
  
  
Time*groups 2,67 26,65 1,80 0,177 
Intensity*groups 1 10 5,54 0,040 
Time*intensity*groups 2 20,02 2,22 0,135 
 
  
  
  
Group 1 vs. Group 2   
  
  
Time 3,03 72,73 523,96 0,000 
Time*groups 3,03 72,73 1,48 0,226 
 
VE (l/min) 
 
DF1 DF2 F sig. 
Time  1,94 21,3 94,36 0,000 
Intensity 1 11 222,30 0,000 
Time*intensity 1,7 18,7 42,61 0,000 
 
  
  
  
G30 vs. G<30   
  
  
Time*groups 1,93 19,3 6,02 0,010 
Intensity*groups 1 10 10,73 0,008 
Time*intensity*groups 2,14 21,44 6,61 0,005 
 
  
  
  
Group 1 vs. Group 2   
  
  
Time 1,97 47,17 227,54 0,000 
Time*groups 1,97 47,17 0,44 0,645 
 
La (mmol/l) 
 
DF1 DF2 F sig. 
Time  1,14 10,21 59,63 0,000 
Intensity 1 9 115,30 0,000 
Time*intensity 1,21 10,87 65,28 0,000 
 
  
  
  
G30 vs. G<30   
  
  
Time*groups 1,17 9,33 4,74 0,052 
Intensity*groups 1 8 2,87 0,129 
Time*intensity*groups 1,29 10,34 5,07 0,040 
 
  
  
  
Group 1 vs. Group 2   
  
  
Time 1,17 24,46 130,37 0,000 
Time*groups 1,17 24,46 0,64 0,454 
 
HR (bpm) 
DF1 DF2 F sig. 
1,5 19,49 59,82 0,000 
1 13 614,39 0,000 
1,36 17,61 33,32 0,000 
  
  
  
  
  
  
1,57 18,84 2,14 0,153 
1 12 1,31 0,275 
1,41 16,96 2,44 0,129 
  
  
  
  
  
  
1,32 31,65 141,06 0,000 
1,32 31,65 0,49 0,540 
RER 
DF1 DF2 F sig. 
2,65 29,18 39,73 0,000 
1 11 128,30 0,000 
2,24 24,69 44,11 0,000 
  
  
  
  
  
  
2,77 27,72 2,32 0,102 
1 10 9,69 0,011 
2,09 0,07 0,56 0,587 
  
  
  
  
  
  
3 72,09 197,50 0,000 
3 72,09 0,66 0,577 
Borg 
DF1 DF2 F sig. 
2 26 47,06 0,000 
1 13 342,36 0,000 
2 26 15,85 0,000 
  
  
  
  
  
  
2 24 1,17 0,329 
1 12 0,01 0,933 
2 24 8,48 0,002 
  
  
  
  
  
  
2 48 96,48 0,000 
2 48 0,63 0,536 
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Appendix III. ANOVA repeated measurement analysis of systemic variables 0-30 min. 
pVO2 
 
DF1 DF2 F sig. 
Time 9 45 172,26 0,000 
Time*Intensity 9 45 11,63 0,000 
 
HR 
 
DF1 DF2 F sig. 
Time 9 45 74,87 0,000 
Time*Intensity 9 45 22,07 0,000 
 
VE 
 
DF1 DF2 F sig. 
Time 9 45 39,03 0,000 
Time*Intensity 9 45 24,5 0,000 
 
RER 
 
DF1 DF2 F sig. 
Time 9 45 9,95 0,000 
Time*Intensity 9 45 21,8 0,000 
 
La 
 
DF1 DF2 F sig. 
Time 10 30 44,5 0,000 
Time*Intensity 10 30 62,89 0,000 
 
Borg 
 
DF1 DF2 F sig. 
Time 5 25 28,8 0,000 
Time*Intensity 1,17 5,85 0,68 0,464 
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Appendix IV. ANOVA RM analysis of O2Hb concentration changes 0-15 min. 
 
vastus lateralis (VL) 
 
DF1 DF2 F sig. 
Time  1,98 23,78 25,91 0,000 
Intensity 1 12 25,41 0,000 
Time*intensity 2,5 30,02 32,85 0,000 
 
  
  
  
G30 vs. G<30   
  
  
Time*groups 1,92 21,13 1,17 0,329 
Intensity*groups 1 11 0,34 0,572 
Time*intensity*groups 2,39 26,29 0,62 0,571 
 
  
  
  
Group 1 vs. Group 2   
  
  
Time 1,9 41,74 44,70 0,000 
Time*groups 1,9 41,74 0,62 0,537 
 
 
biceps femoris (BF) 
 
DF1 DF2 F sig. 
Time  1,43 17,12 37,31 0,000 
Intensity 1 12 0,54 0,477 
Time*intensity 2,1 25,16 11,04 0,000 
 
  
  
  
G30 vs. G<30   
  
  
Time*groups 1,5 16,48 2,54 0,120 
Intensity*groups 1 11 3,09 0,107 
Time*intensity*groups 2,56 28,13 3,80 0,026 
 
  
  
  
Group 1 vs. Group 2   
  
  
Time 1,61 35,49 28,78 0,000 
Time*groups 1,61 35,49 0,48 0,580 
 
 
gastrocnemius lateralis (GL) 
 
DF1 DF2 F sig. 
Time  1,96 23,55 35,92 0,000 
Intensity 1 12 0,02 0,898 
Time*intensity 2,35 28,21 22,01 0,000 
 
  
  
  
G30 vs. G<30   
  
  
Time*groups 2 21,95 1,17 0,330 
Intensity*groups 1 11 0,58 0,462 
Time*intensity*groups 2,36 25,93 0,36 0,738 
 
  
  
  
Group 1 vs. Group 2   
  
  
Time 2,15 47,29 22,60 0,000 
Time*groups 2,15 47,29 0,80 0,465 
 
vastus medialis (VM) 
DF1 DF2 F sig. 
1,96 23,57 37,67 0,000 
1 12 0,13 0,722 
2,37 28,44 17,88 0,000 
  
  
  
  
  
  
1,88 20,67 0,34 0,704 
1 11 0,94 0,353 
2,19 24,05 1,80 0,184 
  
  
  
  
  
  
1,82 40,05 38,12 0,000 
1,82 40,05 0,20 0,803 
gluteus maximus (Gmax) 
DF1 DF2 F sig. 
1,63 19,61 29,85 0,000 
1 12 0,19 0,672 
1,96 26,53 13,17 0,000 
  
  
  
  
  
  
1,81 19,91 3,59 0,051 
1 11 0,28 0,606 
1,94 21,35 1,42 0,264 
  
  
  
  
  
  
1,56 34,33 14,79 0,000 
1,56 34,33 0,57 0,528 
tibialis anterior (TA) 
DF1 DF2 F sig. 
2,83 33,95 28,30 0,000 
1 12 0,40 0,537 
2,96 35,48 2,08 0,121 
  
  
  
  
  
  
2,89 31,8 0,66 0,578 
1 11 0,21 0,655 
2,82 30,96 0,61 0,602 
  
  
  
  
  
  
2,79 61,34 15,02 0,000 
2,79 61,34 0,74 0,524 
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Appendix V. ANOVA RM analysis of O2Hb concentration changes 0-30 min. 
 
vastus lateralis (VL) 
 
DF1 DF2 F sig. 
Time 10 50 12,46 0,000 
Time*Intensity 10 50 29,88 0,000 
 
 
vastus medialis (VM) 
 
DF1 DF2 F sig. 
Time 10 50 37,14 0,000 
Time*Intensity 10 50 14,84 0,000 
 
 
biceps femoris (BF) 
 
DF1 DF2 F sig. 
Time 10 50 16,73 0,000 
Time*Intensity 10 50 4,84 0,000 
 
 
gluteus maximus (Gmax) 
 
DF1 DF2 F sig. 
Time 10 50 66,45 0,000 
Time*Intensity 10 50 9,8 0,000 
 
 
gastrocnemius lateralis (GL) 
 
DF1 DF2 F sig. 
Time 10 50 16,56 0,000 
Time*Intensity 10 50 9,81 0,000 
 
 
tibialis anterior (TA) 
 
DF1 DF2 F sig. 
Time 10 50 7,51 0,000 
Time*Intensity 10 50 1,56 0,146 
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Appendix VI. ANOVA RM analysis of HHb concentration changes 0-15 min. 
 
vastus lateralis (VL) 
 
DF1 DF2 F sig. 
Time  1,48 17,78 34,97 0,000 
Intensity 1 12 26,79 0,000 
Time*intensity 1,54 18,51 16,14 0,000 
 
  
  
  
G30 vs. G<30   
  
  
Time*groups 1,49 16,42 0,33 0,662 
Intensity*groups 1 11 24,70 0,828 
Time*intensity*groups 1,51 16,6 0,25 0,717 
 
  
  
  
Group 1 vs. Group 2   
  
  
Time 1,42 31,33 69,01 0,000 
Time*groups 1,42 31,33 0,81 0,415 
 
 
biceps femoris (BF) 
 
DF1 DF2 F sig. 
Time  1,55 18,6 7,88 0,005 
Intensity 1 12 44,12 0,000 
Time*intensity 2,24 26,87 26,35 0,000 
 
  
  
  
G30 vs. G<30   
  
  
Time*groups 1,55 17,05 0,69 0,480 
Intensity*groups 1 11 6,40 0,028 
Time*intensity*groups 2,36 25,94 2,46 0,097 
 
  
  
  
Group 1 vs. Group 2   
  
  
Time 1,53 33,56 35,56 0,000 
Time*groups 1,53 33,56 0,46 0,000 
 
 
gastrocnemius lateralis (GL) 
 
DF1 DF2 F sig. 
Time  1,69 20,22 9,31 0,002 
Intensity 1 12 7,20 0,020 
Time*intensity 2,35 28,14 10,23 0,000 
 
  
  
  
G30 vs. G<30   
  
  
Time*groups 1,93 21,2 3,35 0,056 
Intensity*groups 1 11 1,03 0,331 
Time*intensity*groups 2,37 26,08 0,97 0,404 
 
  
  
  
Group 1 vs. Group 2   
  
  
Time 2,19 48,07 36,14 0,000 
Time*groups 2,19 48,07 1,56 0,220 
  
vastus medialis (VM) 
DF1 DF2 F sig. 
1,51 18,11 32,86 0,000 
1 12 18,11 0,001 
2,55 30,6 23,43 0,000 
  
  
  
  
  
  
1,4 15,45 1,55 0,240 
1 11 0,833 0,381 
2,47 27,21 0,49 0,656 
  
  
  
  
  
  
1,72 37,75 79,58 0,000 
1,72 37,75 0,57 0,542 
gluteus maximus (Gmax) 
DF1 DF2 F sig. 
2,64 31,67 4,34 0,014 
1 12 30,42 0,000 
1,76 21,09 29,60 0,000 
  
  
  
  
  
  
2,49 27,42 0,91 0,433 
1 11 0,49 0,497 
1,73 19,06 0,73 0,478 
  
  
  
  
  
  
2,4 52,86 50,21 0,000 
2,4 52,86 1,59 0,211 
 
tibialis anterior (TA) 
DF1 DF2 F sig. 
3,2 38,38 9,12 0,000 
1 12 38,74 0,000 
2,68 32,11 18,20 0,000 
  
  
  
  
  
  
3,11 34,23 0,31 0,827 
1 11 0,07 0,800 
2,58 28,4 0,40 0,728 
  
  
  
  
  
  
2,97 65,29 63,94 0,000 
2,97 65,29 1,96 0,129 
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Appendix VII. ANOVA RM analysis of HHb concentration changes 0-30 min. 
 
vastus lateralis (VL) 
 
DF1 DF2 F sig. 
Time 10 50 26,56 0,000 
Time*Intensity 10 50 8,96 0,000 
 
 
vastus medialis (VM) 
 
DF1 DF2 F sig. 
Time 10 50 25,20 0,000 
Time*Intensity 10 50 8,81 0,000 
 
 
biceps femoris (BF) 
 
DF1 DF2 F sig. 
Time 10 50 3,11 0,004 
Time*Intensity 10 50 11,89 0,000 
 
 
gluteus maximus (Gmax) 
 
DF1 DF2 F sig. 
Time 10 50 0,95 0,496 
Time*Intensity 10 50 10,49 0,000 
 
 
gastrocnemius lateralis (GL) 
 
DF1 DF2 F sig. 
Time 10 50 5,08 0,000 
Time*Intensity 10 50 7,05 0,000 
 
 
tibialis anterior (TA) 
 
DF1 DF2 F sig. 
Time 10 50 3,14 0,003 
Time*Intensity 10 50 11,50 0,000 
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Appendix VIII. ANOVA RM analysis of tHb concentration changes 0-15 min. 
 
vastus lateralis (VL) 
 
DF1 DF2 F sig. 
Time  2,04 24,44 14,80 0,000 
Intensity 1 12 0,23 0,640 
Time*intensity 2,56 30,75 7,21 0,001 
 
  
  
  
G30 vs. G<30   
  
  
Time*groups 2,14 23,55 1,32 0,286 
Intensity*groups 1 11 0,36 0,563 
Time*intensity*groups 2,47 27,12 0,33 0,762 
 
  
  
  
Group 1 vs. Group 2   
  
  
Time 1,78 39,13 8,99 0,001 
Time*groups 1,78 39,13 0,68 0,498 
 
 
biceps femoris (BF) 
 
DF1 DF2 F sig. 
Time  1,96 23,52 33,56 0,000 
Intensity 1 12 9,33 0,010 
Time*intensity 2,18 26,11 4,37 0,021 
 
  
  
  
G30 vs. G<30   
  
  
Time*groups 1,98 21,82 0,64 0,534 
Intensity*groups 1 11 5,47 0,039 
Time*intensity*groups 2,69 29,6 4,15 0,017 
 
  
  
  
Group 1 vs. Group 2   
  
  
Time 1,73 38,01 11,52 0,000 
Time*groups 1,73 38,01 0,92 0,396 
 
 
gastrocnemius lateralis (GL) 
 
DF1 DF2 F sig. 
Time  1,96 23,54 19,93 0,000 
Intensity 1 12 2,56 0,136 
Time*intensity 2,04 24,47 6,14 0,007 
 
  
  
  
G30 vs. G<30   
  
  
Time*groups 1,94 21,39 0,90 0,418 
Intensity*groups 1 11 1,47 0,251 
Time*intensity*groups 2,09 22,99 1,21 0,319 
 
  
  
  
Group 1 vs. Group 2   
  
  
Time 1,95 42,78 7,44 0,002 
Time*groups 1,95 42,78 0,07 0,925 
vastus medialis (VM) 
DF1 DF2 F sig. 
2,43 29,2 19,89 0,000 
1 12 4,16 0,064 
1,78 21,34 5,98 0,011 
  
  
  
  
  
  
2,22 24,4 1,68 0,206 
1 11 1,92 0,149 
1,82 20,06 2,44 0,117 
  
  
  
  
  
  
2,1 46,21 29,69 0,000 
2,1 46,21 0,54 0,593 
gluteus maximus (Gmax) 
DF1 DF2 F sig. 
2,38 28,5 32,47 0,000 
1 12 4,02 0,068 
1,78 21,35 5,35 0,016 
  
  
  
  
  
  
2,43 26,67 1,74 0,190 
1 11 0,01 0,947 
1,68 18,45 0,53 0,566 
  
  
  
  
  
  
1,82 40,05 16,42 0,000 
1,82 40,05 1,44 0,248 
 
tibialis anterior (TA) 
DF1 DF2 F sig. 
2,5 30 12,02 0,000 
1 12 33,86 0,000 
2,16 25,94 17,87 0,000 
  
  
  
  
  
  
2,48 27,24 0,87 0,451 
1 11 0,24 0,633 
2,08 22,9 0,68 0,522 
  
  
  
  
  
  
2,39 52,61 18,73 0,000 
2,39 52,61 0,45 0,674 
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Appendix IX. ANOVA RM analysis of tHb concentration changes 0-30 min. 
 
vastus lateralis (VL) 
 
DF1 DF2 F sig. 
Time 10 50 25,24 0,000 
Time*Intensity 10 50 19,22 0,001 
 
 
vastus medialis (VM) 
 
DF1 DF2 F sig. 
Time 10 50 28,49 0,000 
Time*Intensity 10 50 1,89 0,068 
 
 
biceps femoris (BF) 
 
DF1 DF2 F sig. 
Time 10 50 12,43 0,000 
Time*Intensity 10 50 3,30 0,002 
 
 
gluteus maximus (Gmax) 
 
DF1 DF2 F sig. 
Time 10 50 47,76 0,000 
Time*Intensity 10 50 4,55 0,000 
 
 
gastrocnemius lateralis (GL) 
 
DF1 DF2 F sig. 
Time 10 50 17,44 0,000 
Time*Intensity 10 50 2,76 0,009 
 
 
tibialis anterior (TA) 
 
DF1 DF2 F sig. 
Time 10 50 5,43 0,000 
Time*Intensity 10 50 6,73 0,000 
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Appendix X. ANOVA RM analysis of TSI response 0-15 min. 
 
vastus lateralis (VL) 
 
DF1 DF2 F sig. 
Time  1,33 14,58 28,58 0,000 
Intensity 1 11 48,14 0,000 
Time*intensity 1,8 19,75 19,39 0,000 
 
  
  
  
G30 vs. G<30   
  
  
Time*groups 1,28 12,8 0,19 0,727 
Intensity*groups 1 10 0,38 0,551 
Time*intensity*groups 1,54 15,44 0,97 0,379 
 
  
  
  
Group 1 vs. Group 2   
  
  
Time 1,58 33,08 61,41 0,000 
Time*groups 1,58 33,08 0,81 0,429 
 
 
biceps femoris (BF) 
 
DF1 DF2 F sig. 
Time  1,96 23,56 11,96 0,000 
Intensity 1 12 13,22 0,003 
Time*intensity 1,87 22,47 8,99 0,002 
 
  
  
  
G30 vs. G<30   
  
  
Time*groups 1,86 20,45 0,41 0,653 
Intensity*groups 1 11 8,69 0,013 
Time*intensity*groups 1,72 18,9 0,80 0,447 
 
  
  
  
Group 1 vs. Group 2   
  
  
Time 1,88 41,27 42,41 0,000 
Time*groups 1,88 41,27 0,66 0,511 
 
 
gastrocnemius lateralis (GL) 
 
DF1 DF2 F sig. 
Time  2,15 25,8 21,56 0,000 
Intensity 1 12 13,67 0,003 
Time*intensity 2,93 35,18 11,44 0,000 
 
  
  
  
G30 vs. G<30   
  
  
Time*groups 2,28 25,1 2,23 0,122 
Intensity*groups 1 11 2,69 0,129 
Time*intensity*groups 2,89 31,81 0,34 0,790 
 
  
  
  
Group 1 vs. Group 2   
  
  
Time 3,02 66,33 27,36 0,000 
Time*groups 3,02 66,33 1,36 0,263 
 
vastus medialis (VM) 
DF1 DF2 F sig. 
1,8 21,56 50,11 0,000 
1 12 33,53 0,000 
2,48 29,77 17,87 0,000 
  
  
  
  
  
  
1,73 19,03 0,30 0,714 
1 11 0,03 0,863 
2,42 26,65 0,54 0,623 
  
  
  
  
  
  
1,92 42,16 70,60 0,000 
1,92 42,16 1,17 0,323 
gluteus maximus (Gmax) 
DF1 DF2 F sig. 
1,95 23,35 22,41 0,000 
1 12 12,01 0,005 
1,55 18,62 44,57 0,000 
  
  
  
  
  
  
1,98 21,77 5,99 0,009 
1 11 0,64 0,441 
1,5 16,51 2,17 0,154 
  
  
  
  
  
  
1,99 43,68 46,16 0,000 
1,99 43,68 0,31 0,947 
 
tibialis anterior (TA) 
DF1 DF2 F sig. 
3,27 39,22 8,91 0,000 
1 12 17,51 0,001 
3,17 38,02 11,42 0,000 
  
  
  
  
  
  
3,26 35,85 0,56 0,657 
1 11 6,63 0,026 
3,06 33,66 0,48 0,699 
  
  
  
  
  
  
2,87 63,07 31,32 0,000 
2,87 63,07 1,12 0,355 
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Appendix XI. ANOVA RM analysis of TSI response 0-30 min. 
 
vastus lateralis (VL) 
 
DF1 DF2 F sig. 
Time 10 40 16,59 0,000 
Time*Intensity 10 40 13,73 0,000 
 
 
vastus medialis (VM) 
 
DF1 DF2 F sig. 
Time 10 50 22,19 0,000 
Time*Intensity 10 50 15,89 0,000 
 
 
biceps femoris (BF) 
 
DF1 DF2 F sig. 
Time 10 50 4,23 0,000 
Time*Intensity 10 50 3,34 0,002 
 
 
gluteus maximus (Gmax) 
 
DF1 DF2 F sig. 
Time 10 50 7,20 0,000 
Time*Intensity 10 50 7,97 0,000 
 
 
gastrocnemius lateralis (GL) 
 
DF1 DF2 F sig. 
Time 10 50 4,69 0,000 
Time*Intensity 10 50 10,13 0,000 
 
 
tibialis anterior (TA) 
 
DF1 DF2 F sig. 
Time 10 50 3,61 0,001 
Time*Intensity 10 50 7,21 0,000 
 
